Azerbaijan vs Nicaragua: HIV-positive TB patients on ART (antiretroviral therapy)
Azerbaijan
100.0%
in 2024
Nicaragua
100.0%
in 2023
Azerbaijan rank
1st
Nicaragua rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Azerbaijan
- Nicaragua
How they compare
Azerbaijan currently reports 100.0% against 100.0% in Nicaragua, a difference of 0.0%.
The two have swapped places 4 times across 11 shared years of data; in 2011 it was Nicaragua ahead.
Azerbaijan ranks 1st and Nicaragua ranks 1st of 144 countries.
Nicaragua has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.6% | 90.3% | 13.7% | Nicaragua |
| 2020s | 97.8% | 98.2% | 0.5% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Azerbaijan or Nicaragua?
- Azerbaijan, at 100.0% against 100.0% in Nicaragua as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Azerbaijan and Nicaragua?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Nicaragua?
- 11 years are reported by both, from 2011 to 2023.
- How do Azerbaijan and Nicaragua rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Azerbaijan ranks 1st and Nicaragua ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.